This study which identifies and evaluates the quality of existing systematic reviews on the role of CGRP antibodies in preventing migraine is critical for providing clinicians and patients with the most up-to-date and reliable information to make informed decisions about treatment options. The gene discussed is CALCA; the disease is migraine disorder.